The therapeutic vaccines market is anticipated to expand significantly, with projections indicating an increase from US$ 1,244.94 million in 2024 to US$ 2,934.57 million by 2031. This growth trajectory suggests a compound annual growth rate (CAGR) of 13.0% from 2024 to 2031. Key drivers of this market expansion include the rising incidence of chronic diseases and a surge in investments and funding directed towards vaccine development. However, the growth of the therapeutic vaccines market faces challenges, particularly from regulatory hurdles.
Traditional technologies are inadequate for developing vaccines against emerging pathogens that could lead to pandemics. Therefore, it is crucial to create platforms capable of swiftly responding to pandemic threats and effectively adapting to measures addressing new variants. Innovative vaccine platforms, such as mRNA vaccines, immuno-material-based vaccine technology, nano-drug delivery systems, and viral vector-based vaccines, are transforming the landscape of therapeutic vaccine development. The transition towards more efficient and customizable vaccine technologies has facilitated the creation of vaccines targeting a variety of diseases, including cancers, autoimmune disorders, and infectious diseases. The success of mRNA technology in COVID-19 vaccines highlights its potential for therapeutic applications beyond infectious diseases, extending into areas like cancer and chronic infections. These advanced platforms enable faster, more adaptable, and scalable vaccine production, thereby accelerating the introduction of new therapeutic vaccines.
Researchers are actively working on innovative platforms for future applications. For example, a team at the Wyss Institute at Harvard University is pioneering a vaccine platform called OMNIVAX. This "first-in-class immuno-material-based" vaccine technology aims to develop safe and effective therapeutic and prophylactic vaccines against both viral and bacterial infections. Upon administration, OMNIVAX vaccines create a scaffold that attracts dendritic immune cells, programming them to target specific antigens. These cells are subsequently released and migrate to nearby lymph nodes, where they trigger a systemic and prolonged immune response. The modular nature of this technology allows for the incorporation of multiple antigens into a single OMNIVAX vaccine. Such advancements in vaccine technology are expected to introduce new trends in the therapeutic vaccines market in the near future.
End User-Based Insights
The therapeutic vaccines market is categorized based on end users into hospitals, clinics, and other facilities. In 2024, the hospitals segment is projected to hold the largest share of the therapeutic vaccines market. Therapeutic vaccines are increasingly recognized as essential components in the treatment of cancer and other chronic diseases, which are often managed within hospital environments. Hospitals possess the advanced infrastructure necessary for administering specialized therapies targeting cancer and autoimmune diseases. As the global prevalence of chronic diseases, particularly cancer, continues to rise, hospitals are expected to maintain a steady demand for these treatments. They provide comprehensive care, including diagnostic services, treatment, and post-therapy monitoring, all of which are vital for patients receiving therapeutic vaccine treatments. Furthermore, an increase in hospital-based research and clinical trials is contributing to the growth of the therapeutic vaccines market within this segment. Many therapeutic vaccines are tested in hospital settings, allowing healthcare professionals to remain informed about the latest developments in vaccines and treatments, thereby driving the growth of the therapeutic vaccines market.
In preparing the therapeutic vaccines market report, various primary and secondary sources were utilized, including the World Health Organization (WHO), Global Cancer Facts & Figures, and the American Cancer Society.
TABLE OF CONTENTS
1. Introduction
1.1 Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
 3.2.1 Hypothesis formulation:
 3.2.2 Macro-economic factor analysis:
 3.2.3 Developing base number:
 3.2.4 Data Triangulation:
 3.2.5 Country level data:
4. Therapeutic Vaccines Market Landscape
4.1 Overview
4.2 PEST Analysis
5. Therapeutic Vaccines Market - Key Market Dynamics
5.1 Therapeutic Vaccines Market - Key Market Dynamics
5.2 Market Drivers
 5.2.1 Rising Prevalence of Chronic Conditions
 5.2.2 Increasing Investments and Funding for Vaccine Development
5.3 Market Restraints
 5.3.1 Regulatory Challenges
5.4 Market Opportunities
 5.4.1 Extending Product Pipeline
5.5 Future Trends
 5.5.1 Advancements in Vaccine Technology
5.6 Impact of Drivers and Restraints:
6. Therapeutic Vaccines Market - Global Market Analysis
6.1 Therapeutic Vaccines Market Revenue (US$ Thousand), 2021-2031
6.2 Therapeutic Vaccines Market Forecast Analysis
7. Therapeutic Vaccines Market Analysis - by Product
7.1 Cancer Vaccines
 7.1.1 Overview
 7.1.2 Cancer Vaccines: Therapeutic Vaccines Market - Revenue and Forecast to 2031 (US$ Thousand)
7.2 Infectious Disease Vaccines
 7.2.1 Overview
 7.2.2 Infectious Disease Vaccines: Therapeutic Vaccines Market - Revenue and Forecast to 2031 (US$ Thousand)
7.3 Others
 7.3.1 Overview
 7.3.2 Others: Therapeutic Vaccines Market - Revenue and Forecast to 2031 (US$ Thousand)
8. Therapeutic Vaccines Market Analysis - by Technology
8.1 Allogenic Vaccine
 8.1.1 Overview
 8.1.2 Allogenic Vaccine: Therapeutic Vaccines Market - Revenue and Forecast to 2031 (US$ Thousand)
8.2 Autologous Vaccine
 8.2.1 Overview
 8.2.2 Autologous Vaccine: Therapeutic Vaccines Market - Revenue and Forecast to 2031 (US$ Thousand)
9. Therapeutic Vaccines Market Analysis - by End User
9.1 Hospitals
 9.1.1 Overview
 9.1.2 Hospitals: Therapeutic Vaccines Market - Revenue and Forecast to 2031 (US$ Thousand)
9.2 Clinics
 9.2.1 Overview
 9.2.2 Clinics: Therapeutic Vaccines Market - Revenue and Forecast to 2031 (US$ Thousand)
9.3 Others
 9.3.1 Overview
 9.3.2 Others: Therapeutic Vaccines Market - Revenue and Forecast to 2031 (US$ Thousand)
10. Therapeutic Vaccines Market - Geographical Analysis
10.1 North America
 10.1.1 North America Therapeutic Vaccines Market Overview
 10.1.2 North America: Therapeutic Vaccines Market - Revenue and Forecast to 2031 (US$ Thousand)
 10.1.2.1 North America: Therapeutic Vaccines Market - Revenue and Forecast Analysis - by Product
 10.1.2.2 North America: Therapeutic Vaccines Market - Revenue and Forecast Analysis - by Technology
 10.1.2.3 North America: Therapeutic Vaccines Market - Revenue and Forecast Analysis - by End User
 10.1.3 North America: Therapeutic Vaccines Market - Revenue and Forecast Analysis - by Country
 10.1.3.1 United States: Therapeutic Vaccines Market - Revenue and Forecast to 2031 (US$ Thousand)
 10.1.3.1.1 United States: Therapeutic Vaccines Market Breakdown, by Product
 10.1.3.1.2 United States: Therapeutic Vaccines Market Breakdown, by Technology
 10.1.3.1.3 United States: Therapeutic Vaccines Market Breakdown, by End User
 10.1.3.2 Canada: Therapeutic Vaccines Market - Revenue and Forecast to 2031 (US$ Thousand)
 10.1.3.2.1 Canada: Therapeutic Vaccines Market Breakdown, by Product
 10.1.3.2.2 Canada: Therapeutic Vaccines Market Breakdown, by Technology
 10.1.3.2.3 Canada: Therapeutic Vaccines Market Breakdown, by End User
 10.1.3.3 Mexico: Therapeutic Vaccines Market - Revenue and Forecast to 2031 (US$ Thousand)
 10.1.3.3.1 Mexico: Therapeutic Vaccines Market Breakdown, by Product
 10.1.3.3.2 Mexico: Therapeutic Vaccines Market Breakdown, by Technology
 10.1.3.3.3 Mexico: Therapeutic Vaccines Market Breakdown, by End User
10.2 Europe
 10.2.1 Europe Therapeutic Vaccines Market Overview
 10.2.2 Europe: Therapeutic Vaccines Market - Revenue and Forecast to 2031 (US$ Thousand)
 10.2.2.1 Europe: Therapeutic Vaccines Market - Revenue and Forecast Analysis - by Product
 10.2.2.2 Europe: Therapeutic Vaccines Market - Revenue and Forecast Analysis - by Technology
 10.2.2.3 Europe: Therapeutic Vaccines Market - Revenue and Forecast Analysis - by End User
 10.2.3 Europe: Therapeutic Vaccines Market - Revenue and Forecast Analysis - by Country
 10.2.3.1 Germany: Therapeutic Vaccines Market - Revenue and Forecast to 2031 (US$ Thousand)
 10.2.3.1.1 Germany: Therapeutic Vaccines Market Breakdown, by Product
 10.2.3.1.2 Germany: Therapeutic Vaccines Market Breakdown, by Technology
 10.2.3.1.3 Germany: Therapeutic Vaccines Market Breakdown, by End User
 10.2.3.2 United Kingdom: Therapeutic Vaccines Market - Revenue and Forecast to 2031 (US$ Thousand)
 10.2.3.2.1 United Kingdom: Therapeutic Vaccines Market Breakdown, by Product
 10.2.3.2.2 United Kingdom: Therapeutic Vaccines Market Breakdown, by Technology
 10.2.3.2.3 United Kingdom: Therapeutic Vaccines Market Breakdown, by End User
 10.2.3.3 France: Therapeutic Vaccines Market - Revenue and Forecast to 2031 (US$ Thousand)
 10.2.3.3.1 France: Therapeutic Vaccines Market Breakdown, by Product
 10.2.3.3.2 France: Therapeutic Vaccines Market Breakdown, by Technology
 10.2.3.3.3 France: Therapeutic Vaccines Market Breakdown, by End User
 10.2.3.4 Italy: Therapeutic Vaccines Market - Revenue and Forecast to 2031 (US$ Thousand)
 10.2.3.4.1 Italy: Therapeutic Vaccines Market Breakdown, by Product
 10.2.3.4.2 Italy: Therapeutic Vaccines Market Breakdown, by Technology
 10.2.3.4.3 Italy: Therapeutic Vaccines Market Breakdown, by End User
 10.2.3.5 Spain: Therapeutic Vaccines Market - Revenue and Forecast to 2031 (US$ Thousand)
 10.2.3.5.1 Spain: Therapeutic Vaccines Market Breakdown, by Product
 10.2.3.5.2 Spain: Therapeutic Vaccines Market Breakdown, by Technology
 10.2.3.5.3 Spain: Therapeutic Vaccines Market Breakdown, by End User
 10.2.3.6 Rest of Europe: Therapeutic Vaccines Market - Revenue and Forecast to 2031 (US$ Thousand)
 10.2.3.6.1 Rest of Europe: Therapeutic Vaccines Market Breakdown, by Product
 10.2.3.6.2 Rest of Europe: Therapeutic Vaccines Market Breakdown, by Technology
 10.2.3.6.3 Rest of Europe: Therapeutic Vaccines Market Breakdown, by End User
10.3 Asia Pacific
 10.3.1 Asia Pacific Therapeutic Vaccines Market Overview
 10.3.2 Asia Pacific: Therapeutic Vaccines Market - Revenue and Forecast to 2031 (US$ Thousand)
 10.3.2.1 Asia Pacific: Therapeutic Vaccines Market - Revenue and Forecast Analysis - by Product
 10.3.2.2 Asia Pacific: Therapeutic Vaccines Market - Revenue and Forecast Analysis - by Technology
 10.3.2.3 Asia Pacific: Therapeutic Vaccines Market - Revenue and Forecast Analysis - by End User
 10.3.3 Asia Pacific: Therapeutic Vaccines Market - Revenue and Forecast Analysis - by Country
 10.3.3.1 China: Therapeutic Vaccines Market - Revenue and Forecast to 2031 (US$ Thousand)
 10.3.3.1.1 China: Therapeutic Vaccines Market Breakdown, by Product
 10.3.3.1.2 China: Therapeutic Vaccines Market Breakdown, by Technology
 10.3.3.1.3 China: Therapeutic Vaccines Market Breakdown, by End User
 10.3.3.2 Japan: Therapeutic Vaccines Market - Revenue and Forecast to 2031 (US$ Thousand)
 10.3.3.2.1 Japan: Therapeutic Vaccines Market Breakdown, by Product
 10.3.3.2.2 Japan: Therapeutic Vaccines Market Breakdown, by Technology
 10.3.3.2.3 Japan: Therapeutic Vaccines Market Breakdown, by End User
 10.3.3.3 India: Therapeutic Vaccines Market - Revenue and Forecast to 2031 (US$ Thousand)
 10.3.3.3.1 India: Therapeutic Vaccines Market Breakdown, by Product
 10.3.3.3.2 India: Therapeutic Vaccines Market Breakdown, by Technology
 10.3.3.3.3 India: Therapeutic Vaccines Market Breakdown, by End User
 10.3.3.4 South Korea: Therapeutic Vaccines Market - Revenue and Forecast to 2031 (US$ Thousand)
 10.3.3.4.1 South Korea: Therapeutic Vaccines Market Breakdown, by Product
 10.3.3.4.2 South Korea: Therapeutic Vaccines Market Breakdown, by Technology
 10.3.3.4.3 South Korea: Therapeutic Vaccines Market Breakdown, by End User
 10.3.3.5 Australia: Therapeutic Vaccines Market - Revenue and Forecast to 2031 (US$ Thousand)
 10.3.3.5.1 Australia: Therapeutic Vaccines Market Breakdown, by Product
 10.3.3.5.2 Australia: Therapeutic Vaccines Market Breakdown, by Technology
 10.3.3.5.3 Australia: Therapeutic Vaccines Market Breakdown, by End User
 10.3.3.6 Rest of APAC: Therapeutic Vaccines Market - Revenue and Forecast to 2031 (US$ Thousand)
 10.3.3.6.1 Rest of APAC: Therapeutic Vaccines Market Breakdown, by Product
 10.3.3.6.2 Rest of APAC: Therapeutic Vaccines Market Breakdown, by Technology
 10.3.3.6.3 Rest of APAC: Therapeutic Vaccines Market Breakdown, by End User
10.4 Middle East & Africa
 10.4.1 Middle East & Africa Therapeutic Vaccines Market Overview
 10.4.2 Middle East & Africa: Therapeutic Vaccines Market - Revenue and Forecast to 2031 (US$ Thousand)
 10.4.2.1 Middle East & Africa: Therapeutic Vaccines Market - Revenue and Forecast Analysis - by Product
 10.4.2.2 Middle East & Africa: Therapeutic Vaccines Market - Revenue and Forecast Analysis - by Technology
 10.4.2.3 Middle East & Africa: Therapeutic Vaccines Market - Revenue and Forecast Analysis - by End User
 10.4.3 Middle East & Africa: Therapeutic Vaccines Market - Revenue and Forecast Analysis - by Country
 10.4.3.1 Saudi Arabia: Therapeutic Vaccines Market - Revenue and Forecast to 2031 (US$ Thousand)
 10.4.3.1.1 Saudi Arabia: Therapeutic Vaccines Market Breakdown, by Product
 10.4.3.1.2 Saudi Arabia: Therapeutic Vaccines Market Breakdown, by Technology
 10.4.3.1.3 Saudi Arabia: Therapeutic Vaccines Market Breakdown, by End User
 10.4.3.2 South Africa: Therapeutic Vaccines Market - Revenue and Forecast to 2031 (US$ Thousand)
 10.4.3.2.1 South Africa: Therapeutic Vaccines Market Breakdown, by Product
 10.4.3.2.2 South Africa: Therapeutic Vaccines Market Breakdown, by Technology
 10.4.3.2.3 South Africa: Therapeutic Vaccines Market Breakdown, by End User
 10.4.3.3 United Arab Emirates: Therapeutic Vaccines Market - Revenue and Forecast to 2031 (US$ Thousand)
 10.4.3.3.1 United Arab Emirates: Therapeutic Vaccines Market Breakdown, by Product
 10.4.3.3.2 United Arab Emirates: Therapeutic Vaccines Market Breakdown, by Technology
 10.4.3.3.3 United Arab Emirates: Therapeutic Vaccines Market Breakdown, by End User
 10.4.3.4 Rest of Middle East & Africa: Therapeutic Vaccines Market - Revenue and Forecast to 2031 (US$ Thousand)
 10.4.3.4.1 Rest of Middle East & Africa: Therapeutic Vaccines Market Breakdown, by Product
 10.4.3.4.2 Rest of Middle East & Africa: Therapeutic Vaccines Market Breakdown, by Technology
 10.4.3.4.3 Rest of Middle East & Africa: Therapeutic Vaccines Market Breakdown, by End User
10.5 South & Central America
 10.5.1 South & Central America Therapeutic Vaccines Market Overview
 10.5.2 South & Central America: Therapeutic Vaccines Market - Revenue and Forecast to 2031 (US$ Thousand)
 10.5.2.1 South & Central America: Therapeutic Vaccines Market - Revenue and Forecast Analysis - by Product
 10.5.2.2 South & Central America: Therapeutic Vaccines Market - Revenue and Forecast Analysis - by Technology
 10.5.2.3 South & Central America: Therapeutic Vaccines Market - Revenue and Forecast Analysis - by End User
 10.5.3 South & Central America: Therapeutic Vaccines Market - Revenue and Forecast Analysis - by Country
 10.5.3.1 Brazil: Therapeutic Vaccines Market - Revenue and Forecast to 2031 (US$ Thousand)
 10.5.3.1.1 Brazil: Therapeutic Vaccines Market Breakdown, by Product
 10.5.3.1.2 Brazil: Therapeutic Vaccines Market Breakdown, by Technology
 10.5.3.1.3 Brazil: Therapeutic Vaccines Market Breakdown, by End User
 10.5.3.2 Argentina: Therapeutic Vaccines Market - Revenue and Forecast to 2031 (US$ Thousand)
 10.5.3.2.1 Argentina: Therapeutic Vaccines Market Breakdown, by Product
 10.5.3.2.2 Argentina: Therapeutic Vaccines Market Breakdown, by Technology
 10.5.3.2.3 Argentina: Therapeutic Vaccines Market Breakdown, by End User
 10.5.3.3 Rest of South & Central America: Therapeutic Vaccines Market - Revenue and Forecast to 2031 (US$ Thousand)
 10.5.3.3.1 Rest of South & Central America: Therapeutic Vaccines Market Breakdown, by Product
 10.5.3.3.2 Rest of South & Central America: Therapeutic Vaccines Market Breakdown, by Technology
 10.5.3.3.3 Rest of South & Central America: Therapeutic Vaccines Market Breakdown, by End User
11. Therapeutic Vaccines Market - Industry Landscape
11.1 Overview
11.2 Growth Strategies in the Therapeutic Vaccines Market
11.3 Organic Growth Strategies
 11.3.1 Overview
11.4 Inorganic Growth Strategies
 11.4.1 Overview
12. Company Profiles
12.1 Dendreon
 12.1.1 Key Facts
 12.1.2 Business Description
 12.1.3 Products and Services
 12.1.4 Financial Overview
 12.1.5 SWOT Analysis
 12.1.6 Key Developments
12.2 BioNTech SE
 12.2.1 Key Facts
 12.2.2 Business Description
 12.2.3 Products and Services
 12.2.4 Financial Overview
 12.2.5 SWOT Analysis
 12.2.6 Key Developments
12.3 Serum Institute of India Pvt. Ltd
 12.3.1 Key Facts
 12.3.2 Business Description
 12.3.3 Products and Services
 12.3.4 Financial Overview
 12.3.5 SWOT Analysis
 12.3.6 Key Developments
12.4 Merck & Co Inc
 12.4.1 Key Facts
 12.4.2 Business Description
 12.4.3 Products and Services
 12.4.4 Financial Overview
 12.4.5 SWOT Analysis
 12.4.6 Key Developments
12.5 Amgen Inc
 12.5.1 Key Facts
 12.5.2 Business Description
 12.5.3 Products and Services
 12.5.4 Financial Overview
 12.5.5 SWOT Analysis
 12.5.6 Key Developments
12.6 ISA Pharmaceuticals BV
 12.6.1 Key Facts
 12.6.2 Business Description
 12.6.3 Products and Services
 12.6.4 Financial Overview
 12.6.5 SWOT Analysis
 12.6.6 Key Developments
12.7 INOVIO Pharmaceuticals Inc
 12.7.1 Key Facts
 12.7.2 Business Description
 12.7.3 Products and Services
 12.7.4 Financial Overview
 12.7.5 SWOT Analysis
 12.7.6 Key Developments
12.8 Transgene SA
 12.8.1 Key Facts
 12.8.2 Business Description
 12.8.3 Products and Services
 12.8.4 Financial Overview
 12.8.5 SWOT Analysis
 12.8.6 Key Developments
12.9 THERAVECTYS SA
 12.9.1 Key Facts
 12.9.2 Business Description
 12.9.3 Products and Services
 12.9.4 Financial Overview
 12.9.5 SWOT Analysis
 12.9.6 Key Developments
12.10 CureVac SE
 12.10.1 Key Facts
 12.10.2 Business Description
 12.10.3 Products and Services
 12.10.4 Financial Overview
 12.10.5 SWOT Analysis
 12.10.6 Key Developments
13. Appendix
13.1 About
13.2 Glossary of Terms
LIST OF TABLES
Table 1. Therapeutic Vaccines Market Segmentation
Table 2. North America: Therapeutic Vaccines Market - Revenue and Forecast to 2031(US$ Thousand) - by Product
Table 3. North America: Therapeutic Vaccines Market - Revenue and Forecast to 2031(US$ Thousand) - by Technology
Table 4. North America: Therapeutic Vaccines Market - Revenue and Forecast to 2031(US$ Thousand) - by End User
Table 5. United States: Therapeutic Vaccines Market - Revenue and Forecast to 2031(US$ Thousand) - by Product
Table 6. United States: Therapeutic Vaccines Market - Revenue and Forecast to 2031(US$ Thousand) - by Technology
Table 7. United States: Therapeutic Vaccines Market - Revenue and Forecast to 2031(US$ Thousand) - by End User
Table 8. Canada: Therapeutic Vaccines Market - Revenue and Forecast to 2031(US$ Thousand) - by Product
Table 9. Canada: Therapeutic Vaccines Market - Revenue and Forecast to 2031(US$ Thousand) - by Technology
Table 10. Canada: Therapeutic Vaccines Market - Revenue and Forecast to 2031(US$ Thousand) - by End User
Table 11. Mexico: Therapeutic Vaccines Market - Revenue and Forecast to 2031(US$ Thousand) - by Product
Table 12. Mexico: Therapeutic Vaccines Market - Revenue and Forecast to 2031(US$ Thousand) - by Technology
Table 13. Mexico: Therapeutic Vaccines Market - Revenue and Forecast to 2031(US$ Thousand) - by End User
Table 14. Europe: Therapeutic Vaccines Market - Revenue and Forecast to 2031(US$ Thousand) - by Product
Table 15. Europe: Therapeutic Vaccines Market - Revenue and Forecast to 2031(US$ Thousand) - by Technology
Table 16. Europe: Therapeutic Vaccines Market - Revenue and Forecast to 2031(US$ Thousand) - by End User
Table 17. Germany: Therapeutic Vaccines Market - Revenue and Forecast to 2031(US$ Thousand) - by Product
Table 18. Germany: Therapeutic Vaccines Market - Revenue and Forecast to 2031(US$ Thousand) - by Technology
Table 19. Germany: Therapeutic Vaccines Market - Revenue and Forecast to 2031(US$ Thousand) - by End User
Table 20. United Kingdom: Therapeutic Vaccines Market - Revenue and Forecast to 2031(US$ Thousand) - by Product
Table 21. United Kingdom: Therapeutic Vaccines Market - Revenue and Forecast to 2031(US$ Thousand) - by Technology
Table 22. United Kingdom: Therapeutic Vaccines Market - Revenue and Forecast to 2031(US$ Thousand) - by End User
Table 23. France: Therapeutic Vaccines Market - Revenue and Forecast to 2031(US$ Thousand) - by Product
Table 24. France: Therapeutic Vaccines Market - Revenue and Forecast to 2031(US$ Thousand) - by Technology
Table 25. France: Therapeutic Vaccines Market - Revenue and Forecast to 2031(US$ Thousand) - by End User
Table 26. Italy: Therapeutic Vaccines Market - Revenue and Forecast to 2031(US$ Thousand) - by Product
Table 27. Italy: Therapeutic Vaccines Market - Revenue and Forecast to 2031(US$ Thousand) - by Technology
Table 28. Italy: Therapeutic Vaccines Market - Revenue and Forecast to 2031(US$ Thousand) - by End User
Table 29. Spain: Therapeutic Vaccines Market - Revenue and Forecast to 2031(US$ Thousand) - by Product
Table 30. Spain: Therapeutic Vaccines Market - Revenue and Forecast to 2031(US$ Thousand) - by Technology
Table 31. Spain: Therapeutic Vaccines Market - Revenue and Forecast to 2031(US$ Thousand) - by End User
Table 32. Rest of Europe: Therapeutic Vaccines Market - Revenue and Forecast to 2031(US$ Thousand) - by Product
Table 33. Rest of Europe: Therapeutic Vaccines Market - Revenue and Forecast to 2031(US$ Thousand) - by Technology
Table 34. Rest of Europe: Therapeutic Vaccines Market - Revenue and Forecast to 2031(US$ Thousand) - by End User
Table 35. Asia Pacific: Therapeutic Vaccines Market - Revenue and Forecast to 2031(US$ Thousand) - by Product
Table 36. Asia Pacific: Therapeutic Vaccines Market - Revenue and Forecast to 2031(US$ Thousand) - by Technology
Table 37. Asia Pacific: Therapeutic Vaccines Market - Revenue and Forecast to 2031(US$ Thousand) - by End User
Table 38. China: Therapeutic Vaccines Market - Revenue and Forecast to 2031(US$ Thousand) - by Product
Table 39. China: Therapeutic Vaccines Market - Revenue and Forecast to 2031(US$ Thousand) - by Technology
Table 40. China: Therapeutic Vaccines Market - Revenue and Forecast to 2031(US$ Thousand) - by End User
Table 41. Japan: Therapeutic Vaccines Market - Revenue and Forecast to 2031(US$ Thousand) - by Product
Table 42. Japan: Therapeutic Vaccines Market - Revenue and Forecast to 2031(US$ Thousand) - by Technology
Table 43. Japan: Therapeutic Vaccines Market - Revenue and Forecast to 2031(US$ Thousand) - by End User
Table 44. India: Therapeutic Vaccines Market - Revenue and Forecast to 2031(US$ Thousand) - by Product
Table 45. India: Therapeutic Vaccines Market - Revenue and Forecast to 2031(US$ Thousand) - by Technology
Table 46. India: Therapeutic Vaccines Market - Revenue and Forecast to 2031(US$ Thousand) - by End User
Table 47. South Korea: Therapeutic Vaccines Market - Revenue and Forecast to 2031(US$ Thousand) - by Product
Table 48. South Korea: Therapeutic Vaccines Market - Revenue and Forecast to 2031(US$ Thousand) - by Technology
Table 49. South Korea: Therapeutic Vaccines Market - Revenue and Forecast to 2031(US$ Thousand) - by End User
Table 50. Australia: Therapeutic Vaccines Market - Revenue and Forecast to 2031(US$ Thousand) - by Product
Table 51. Australia: Therapeutic Vaccines Market - Revenue and Forecast to 2031(US$ Thousand) - by Technology
Table 52. Australia: Therapeutic Vaccines Market - Revenue and Forecast to 2031(US$ Thousand) - by End User
Table 53. Rest of APAC: Therapeutic Vaccines Market - Revenue and Forecast to 2031(US$ Thousand) - by Product
Table 54. Rest of APAC: Therapeutic Vaccines Market - Revenue and Forecast to 2031(US$ Thousand) - by Technology
Table 55. Rest of APAC: Therapeutic Vaccines Market - Revenue and Forecast to 2031(US$ Thousand) - by End User
Table 56. Middle East & Africa: Therapeutic Vaccines Market - Revenue and Forecast to 2031(US$ Thousand) - by Product
Table 57. Middle East & Africa: Therapeutic Vaccines Market - Revenue and Forecast to 2031(US$ Thousand) - by Technology
Table 58. Middle East & Africa: Therapeutic Vaccines Market - Revenue and Forecast to 2031(US$ Thousand) - by End User
Table 59. Saudi Arabia: Therapeutic Vaccines Market - Revenue and Forecast to 2031(US$ Thousand) - by Product
Table 60. Saudi Arabia: Therapeutic Vaccines Market - Revenue and Forecast to 2031(US$ Thousand) - by Technology
Table 61. Saudi Arabia: Therapeutic Vaccines Market - Revenue and Forecast to 2031(US$ Thousand) - by End User
Table 62. South Africa: Therapeutic Vaccines Market - Revenue and Forecast to 2031(US$ Thousand) - by Product
Table 63. South Africa: Therapeutic Vaccines Market - Revenue and Forecast to 2031(US$ Thousand) - by Technology
Table 64. South Africa: Therapeutic Vaccines Market - Revenue and Forecast to 2031(US$ Thousand) - by End User
Table 65. United Arab Emirates: Therapeutic Vaccines Market - Revenue and Forecast to 2031(US$ Thousand) - by Product
Table 66. United Arab Emirates: Therapeutic Vaccines Market - Revenue and Forecast to 2031(US$ Thousand) - by Technology
Table 67. United Arab Emirates: Therapeutic Vaccines Market - Revenue and Forecast to 2031(US$ Thousand) - by End User
Table 68. Rest of Middle East & Africa: Therapeutic Vaccines Market - Revenue and Forecast to 2031(US$ Thousand) - by Product
Table 69. Rest of Middle East & Africa: Therapeutic Vaccines Market - Revenue and Forecast to 2031(US$ Thousand) - by Technology
Table 70. Rest of Middle East & Africa: Therapeutic Vaccines Market - Revenue and Forecast to 2031(US$ Thousand) - by End User
Table 71. South & Central America: Therapeutic Vaccines Market - Revenue and Forecast to 2031(US$ Thousand) - by Product
Table 72. South & Central America: Therapeutic Vaccines Market - Revenue and Forecast to 2031(US$ Thousand) - by Technology
Table 73. South & Central America: Therapeutic Vaccines Market - Revenue and Forecast to 2031(US$ Thousand) - by End User
Table 74. Brazil: Therapeutic Vaccines Market - Revenue and Forecast to 2031(US$ Thousand) - by Product
Table 75. Brazil: Therapeutic Vaccines Market - Revenue and Forecast to 2031(US$ Thousand) - by Technology
Table 76. Brazil: Therapeutic Vaccines Market - Revenue and Forecast to 2031(US$ Thousand) - by End User
Table 77. Argentina: Therapeutic Vaccines Market - Revenue and Forecast to 2031(US$ Thousand) - by Product
Table 78. Argentina: Therapeutic Vaccines Market - Revenue and Forecast to 2031(US$ Thousand) - by Technology
Table 79. Argentina: Therapeutic Vaccines Market - Revenue and Forecast to 2031(US$ Thousand) - by End User
Table 80. Rest of South & Central America: Therapeutic Vaccines Market - Revenue and Forecast to 2031(US$ Thousand) - by Product
Table 81. Rest of South & Central America: Therapeutic Vaccines Market - Revenue and Forecast to 2031(US$ Thousand) - by Technology
Table 82. Rest of South & Central America: Therapeutic Vaccines Market - Revenue and Forecast to 2031(US$ Thousand) - by End User
Table 83. Recent Organic Growth Strategies in the Therapeutic Vaccines Market
Table 84. Recent Inorganic Growth Strategies in the Therapeutic Vaccines Market
Table 85. Glossary of Terms, Therapeutic Vaccines Market
LIST OF FIGURES
Figure 1. Therapeutic Vaccines Market Segmentation, by Geography
Figure 2. PEST Analysis
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. Therapeutic Vaccines Market Revenue (US$ Thousand), 2021-2031
Figure 5. Therapeutic Vaccines Market - Revenue and Forecast to 2031 (US$ Thousand)
Figure 6. Therapeutic Vaccines Market Share (%) - by Product (2024 and 2031)
Figure 7. Cancer Vaccines: Therapeutic Vaccines Market - Revenue and Forecast to 2031 (US$ Thousand)
Figure 8. Infectious Disease Vaccines: Therapeutic Vaccines Market - Revenue and Forecast to 2031 (US$ Thousand)
Figure 9. Others: Therapeutic Vaccines Market - Revenue and Forecast to 2031 (US$ Thousand)
Figure 10. Therapeutic Vaccines Market Share (%) - by Technology (2024 and 2031)
Figure 11. Allogenic Vaccine: Therapeutic Vaccines Market - Revenue and Forecast to 2031 (US$ Thousand)
Figure 12. Autologous Vaccine: Therapeutic Vaccines Market - Revenue and Forecast to 2031 (US$ Thousand)
Figure 13. Therapeutic Vaccines Market Share (%) - by End User (2024 and 2031)
Figure 14. Hospitals: Therapeutic Vaccines Market - Revenue and Forecast to 2031 (US$ Thousand)
Figure 15. Clinics: Therapeutic Vaccines Market - Revenue and Forecast to 2031 (US$ Thousand)
Figure 16. Others: Therapeutic Vaccines Market - Revenue and Forecast to 2031 (US$ Thousand)
Figure 17. North America: Therapeutic Vaccines Market - Revenue and Forecast to 2031(US$ Thousand)
Figure 18. North America: Therapeutic Vaccines Market Breakdown, by Key Countries, 2024 and 2031 (%)
Figure 19. United States: Therapeutic Vaccines Market - Revenue and Forecast to 2031(US$ Thousand)
Figure 20. Canada: Therapeutic Vaccines Market - Revenue and Forecast to 2031(US$ Thousand)
Figure 21. Mexico: Therapeutic Vaccines Market - Revenue and Forecast to 2031(US$ Thousand)
Figure 22. Europe: Therapeutic Vaccines Market - Revenue and Forecast to 2031(US$ Thousand)
Figure 23. Europe: Therapeutic Vaccines Market Breakdown, by Key Countries, 2024 and 2031 (%)
Figure 24. Germany: Therapeutic Vaccines Market - Revenue and Forecast to 2031(US$ Thousand)
Figure 25. United Kingdom: Therapeutic Vaccines Market - Revenue and Forecast to 2031(US$ Thousand)
Figure 26. France: Therapeutic Vaccines Market - Revenue and Forecast to 2031(US$ Thousand)
Figure 27. Italy: Therapeutic Vaccines Market - Revenue and Forecast to 2031(US$ Thousand)
Figure 28. Spain: Therapeutic Vaccines Market - Revenue and Forecast to 2031(US$ Thousand)
Figure 29. Rest of Europe: Therapeutic Vaccines Market - Revenue and Forecast to 2031(US$ Thousand)
Figure 30. Asia Pacific: Therapeutic Vaccines Market - Revenue and Forecast to 2031(US$ Thousand)
Figure 31. Asia Pacific: Therapeutic Vaccines Market Breakdown, by Key Countries, 2024 and 2031 (%)
Figure 32. China: Therapeutic Vaccines Market - Revenue and Forecast to 2031(US$ Thousand)
Figure 33. Japan: Therapeutic Vaccines Market - Revenue and Forecast to 2031(US$ Thousand)
Figure 34. India: Therapeutic Vaccines Market - Revenue and Forecast to 2031(US$ Thousand)
Figure 35. South Korea: Therapeutic Vaccines Market - Revenue and Forecast to 2031(US$ Thousand)
Figure 36. Australia: Therapeutic Vaccines Market - Revenue and Forecast to 2031(US$ Thousand)
Figure 37. Rest of APAC: Therapeutic Vaccines Market - Revenue and Forecast to 2031(US$ Thousand)
Figure 38. Middle East & Africa: Therapeutic Vaccines Market - Revenue and Forecast to 2031(US$ Thousand)
Figure 39. Middle East & Africa: Therapeutic Vaccines Market Breakdown, by Key Countries, 2024 and 2031 (%)
Figure 40. Saudi Arabia: Therapeutic Vaccines Market - Revenue and Forecast to 2031(US$ Thousand)
Figure 41. South Africa: Therapeutic Vaccines Market - Revenue and Forecast to 2031(US$ Thousand)
Figure 42. United Arab Emirates: Therapeutic Vaccines Market - Revenue and Forecast to 2031(US$ Thousand)
Figure 43. Rest of Middle East & Africa: Therapeutic Vaccines Market - Revenue and Forecast to 2031(US$ Thousand)
Figure 44. South & Central America: Therapeutic Vaccines Market - Revenue and Forecast to 2031(US$ Thousand)
Figure 45. South & Central America: Therapeutic Vaccines Market Breakdown, by Key Countries, 2024 and 2031 (%)
Figure 46. Brazil: Therapeutic Vaccines Market - Revenue and Forecast to 2031(US$ Thousand)
Figure 47. Argentina: Therapeutic Vaccines Market - Revenue and Forecast to 2031(US$ Thousand)
Figure 48. Rest of South & Central America: Therapeutic Vaccines Market - Revenue and Forecast to 2031(US$ Thousand)
Figure 49. Growth Strategies in the Therapeutic Vaccines Market
The List of Companies - Therapeutic Vaccines Market
- Dendreon
- BioNTech SE
- Serum Institute of India Pvt. Ltd
- Merck & Co Inc
- Amgen Inc.
- ISA Pharmaceuticals BV
- INOVIO Pharmaceuticals Inc
- Transgene SA
- THERAVECTYS SA
- CureVac SE